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Attempts to characterize the proteins in serum responsible for reaginic activity be- 
gan in 1931 when Sherrer, using an ammonium sulfate fractionation technique, dem- 
onstrated that reagin could reside  in both the euglobulins  and  the pseudoglobulins 
but was absent  in the alburnirt  fraction  (2).  Subsequently,  numerous  investigators 
using different techniques found reaginic activity in both gamma and beta globulins as 
classified  on the basis of electrophoretic mobility (3-8), and in 1959, Heimlich et al 
showed that reagin could be associated with either high or low molecular weight im- 
munoglobulius (9).  Also in 1959, Heremans and coworkers demonstrated a new class 
of immunoglobulius which they called B~2~ (10)  and Schultze (11) showed that these 
immunoglobulius  had  antibody  activity. 
Subsequent to 1959, most investigations concerning the nature of reagin have dem- 
onstrated that reaginic activity resides in what is referred to as IgA immunoglobulin 
(B~, 3'1A, ~/A).  1 These investigators have used (a) the zinc sulfate method to partially 
isolate the IgA fraction (13,  14); (b) physical methods to isolate relatively pure IgA 
and immune precipitation of the IgA and IgG fractions (15); (c) isolation of IgA from 
saliva  without  contamination by other  immunoglobulins  (16);  (d)  blocking of the 
Prausnitz-Kiistner (P-K) reaction with purified IgA (17); and (e) blocking of the P-K 
reaction with the heavy chain of IgA which had been isolated after  reduction and 
alkylation  of whole IgA (18). 
Taken as a whole, the literature suggests that the capacity of an immunoglobulin to 
fix to skin and subsequently elicit a P-K reaction is a quality associated with the heavy 
chain of the IgA globulin  (18).  This concept is in keeping with the currently held 
broader principle that the biological characteristics of various immunoglobulins such 
as complement-fixing capacity, placental transfer, and especially skin-fixing  ability is 
conferred by the heavy chain of the immunogiobulin involved. Recently, however, six 
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reports have appeared in the literature (1, 19-23) which indicate that immunoglobu- 
lins, other than IgA, also have the capacity to elicit a P-K reaction. Loveless  (19) and 
Rockey et al. (20) reported a serum devoid of detectable IgA which had P-K reactivity 
against ragweed pollen extract. Perelmutter et al.  (23) described a  serum with both 
IgA and IgG reagin directed against ragweed pollen extract and Terr and Bentz (22) 
described reaginic activity in IgG and IgM immunoglobulins against horse  serum 
proteins. These latter reagins were induced by the injection  of horse serum and the IgG 
portion was resistant to heating to 56°C for 4 hr and to treatment with 0.1 ~r mer- 
captoethanol, whereas the IgM was sensitive to both these procedures. Fireman et al. 
(21) also described a reagin in the IgG class in a patient with telangiectasia ataxia who 
had no IgA in his serum. This reagin also differed from the traditional descriptions of 
reagin in that it was heat stable and remained in the skin for only short periods of time. 
This laboratory (I) described an unusual immunoglobulin  which was heat labile, would 
fix to skin for at least 14 days, and in which the bulk of reaginic activity was found 
outside the IgA class of immunoglobulins.  The present report describes these studies in 
detail together with some studies on four additional sera. 
The  finding  of  reaginic  activity  associated  with  immunoglobulins other 
than IgA suggests the need to reexamine the currently held concepts regarding 
the factors that  are important in determining whether a  particular immuno- 
globulin will or will not fix to skin and confer passively transferrable immuno- 
logic reactivity. 
Materials and Methods 
Antigens.--Crystalline  bovine  serum  albumin  (BSA) (Armour  Pharmaceutical  Co., 
Kankakee, Illinois, lot A69702), house dust, horse dander (10% solution), Lolium perenn* (5% 
solution, perennial rye grass), Cynodon daaylon (5% solution, Bermuda grass pollen), Hollister- 
Stier Laboratories, Los Angeles, were used throughout this study. 
Sera.--Five patients with symptoms of allergic rhinifis and/or bronchial asthma, who had 
strongly positive wheal and flare skin reactions to a number of allergens, were bled and their 
sera separated. For this report, the sera have been designated as Nos. 1, 2, 3, 4, and 5. Serum 
1 was of particular  interest  because of the strong reaginic activity to BSA. Consequently, 
this serum was examined by all the procedures listed below. Sera 2, 3, 4, and 5 were examined 
only by anion exchange chromatography (DEAE) and by the passive transfer (P-K) skin test. 
I=l-Labded BSA.--For radioimmunoelectrophoresis  studies and the antigen-binding capac- 
ity tests described below, the BSA was labeled with Iodine  m (I*BSA) using a modification 
(24) of the chloramine-T method (25). 
Ammonium Sulfate Test (ABC-33).--Anfibody to BSA was measured in duplicate samples 
by precipitating I*BSA-antibody complexes with 50% saturated  ammonium sulfate  (SAS). 
Details of this procedure and the calculations involved were carried out as previously reported 
(26) except that the SAS precipitates were washed once with 3 ml of equal parts of SAS and 
borate buffer. 
Antlgen-Precipltating Capacity (P-80).--The capacity of serum 1 to precipitate BSA was 
measured in duplicate using a  variation  (26) of the  technique described by Talmage and 
Manrer (27) in which a constant amount of I*BSA in 0.5 ml of a 1:100 normal human serum 
diluent was added to 1 ml of serial dilutions of antiserum. 
Microimmunodiffusion.--A  1 mm layer  of ionager  2  (Consolidated Laboratories,  Inc., ROBERT  T. REID~ PERCY MINDEN~  AND RICHARD  S. ]~ARR  847 
Chicago Heights, Illinois) was applied onto microscope slides  and wells cut with a  template 
(LKB Products,  Stockhohn, Sweden). Central walls were filled with whole human serum 1. 
Six peripheral wells were filled with BSA antigen in concentrations ranging from  1.0  mg/ml 
to 0.03 rag/m1. The slides were incubated in a humidified chamber at 4°C for 72 hr, washed with 
normal saline for 48 hr, dried, and the precipitin bands stained with Amido black. 
H~,nagglu~inc~ion studies were performed by the micromethod and  plexiglass plates de- 
scribed by Sever (28).  Sheep ceils were prepared and tanned according to Stavitsky (29). 
Passive cutaneou~ anapkylaxis  (PCA) was performed using a  variation of the technique 
described by Ovary (30).  16 hr after the intradermal injection of 0.1  ml of test serum, the 
guinea pigs were injected intravenously with 1.0 ml of a BSA-Evans blue dye solution con- 
mining 0.2 mg BSA N/ml and  10 nag. Evans blue/nil in saline, the dosage recommended by 
Campbell eta/. (31). 
Immunodectropkoresls  (IF.P)  was  performed  by  the  micromethod  of  Scheidegger  (32). 
Electrophoresis was done on 1 X  3 in. microscope slides covered with 2 ml of 2% agar (Difco 
Laboratories, Inc., Detroit) in 0.0375  ionic strength veronal buffer (pH 8.6)  as the support 
medium. Two outer wells and  a  center trough were cut by an Egaton template  (National 
Instrument  Laboratories,  Washington,  D.  C.).  The  antisera  (Hyland Laboratories, Los 
Angeles) were as follows: (a) goat, anti-human serum, lot 3802TID, 3802U5;  (b) goat, anti-lhA 
globulin, lot 206-7ABS 8962, GP 7964F;  (c) goat, anti-human B~M globulin, lot G37-98  P3316; 
and  (d) goat, anti-human 7S, lot GP 11-63. 
Radioimmunoele~trophoresis was performed by the method of Yagi eta/.  (33) with minor 
modifications.  IEP  plates  were prepared  as  described  above  and  after  washing,  approxi- 
mately 0.1 mi BSA solution containing 1 7-BSA zq/ml and approximately 1.5/zc I13z/7-BSA 
N, was applied to the trough. After standing overnight, the slides were washed for 1 rain with 
distilled water, dried in the open air, and the agar surface applied to the emulsion surface of 
undeveloped  Eastman  Kodak  high  contrast  projector  slide  plates,  Eastman  Kodak  CO., 
Rochester, New York. After 7 days, the exposed plates were developed in the normal manner 
and  the  immunoelectrophoresis  slides  were  stained  with  Azocarmine-G. 
Passive Transfer Test (P-K).--0.1 ml aliquots of the test sera or the fractions under study 
were injected intradermaily into the recipients. At intervals of 24 hr to 14 days, the sites were 
challenged by the intradermal injection of 0.02 ml of the appropriate antigen. The BSA anti- 
gen contained  I  rag/m1 and the other antigens were diluted  1:100 or 1:1000 with buffered 
saline. Skin tests were graded from 0  to 4+  as follows: 
Wheal diameter  Erythema diameter 
gttrt~  ~tWt~ 
-4-  <5  0 
1+  5--10  10-15 
2+  10-13  20-25 
3+  13-15  25-35 
4+  > 15 and pseudopodia  >35 
Anion Exchange Chromatography (DEAE).--All five sera were separated on diethylamino- 
ethylcellulose  (DEAE)  by  stepwise  elution  according  to the  method  of  Sober  eta/.  (34), 
utilizing the following b~ffers: (a) phosphate buffer pH 7.0, 0.01 ~; (b) phosphate buffer pH 
7.0, 0.025  ~;  (c) phosphate buffer pH 6.0, 0.1 ~; and (d) phosphate buffer pH 5, 0.3  M. Before 
application to the col-mn~ the sera were diluted  1:2 and dialyzed overnight against  0.01  M 
dibasic sodium phosphate.  5  mi fractions were collected in a  Rimco fraction collector and 
read  on a  Beckman DU spectrophotometer  at  280  mu.  The peaks  were pooled,  dialyzed, 848  REAGINIC ACTIVITY AND  IGG TMT~UNOGLOBULIN 
lyophiliT,  ed, resuspended in buffered saline, and dialyzed again. They were sterilized by pass- 
ing through a Seitz falter, frozen, and stored at --20°C until tested. Examination of the peaks 
by IEP revealed that peak 1 contained only IgG, peak 2 contained occasional traces of IgG 
and IgA, and peak 3 contained IgA and occasional traces of IgG.  Peak 4 contained IgM 
and occasional traces of IgA and IgG. 
Gd Filtration.--Serum I was fractionated  on Sephadex G-200 (Pharmacia, Upsala, Swe- 
den) using the technique described by Terr and Bentz (35). The column was 116 cm in length, 
3.8 cm in width, and the flow rate 5 to 10 rnl/hr. 5 mi aliquots were collected and the protein 
concentration determined by absorption at 280 mu on the Beckman DU spectrophotometer. 
Pe~ikon Block Elearopkoresis.--Semm 1 was fractionated  using the method  of Mtiller- 
Eberhard  (36). Proteins were migrated on the support medium in veronal buffer pH 8.6, 0.05 
,~. The proteins were electrophoresed at 400 v for 18 hr at 4°C. The block was then cut in 
in. fractions and the  proteins eluted with  buffered saline. Fractions  were immediately 
dialyzed against  phosphate-buffered saline  (pH  7.0), and then concentrated  by negative 
pressure dialysis. Protein  concentrations were determined either by  absorption at 280 mu 
on  a  Beckman  Spectrophotometer or  by the  Lowry  modification  of  the  Folin-Cicolteau 
method (37). 
Density gradient ultracentrifugation was performed as described by Kunkel (38). Serum 1 
was diluted 1:2 and 1 mi layered over the top of a 4 ml sucrose density gradient of from 10 
to 40% sucrose and spun for a total of 16 hr at 35,000 ~x, in a Spinco model L ultracentrifuge 
using a SW-39 head. The fractions were collected by perforating the bottom of the plastic 
tube with a needle and collecting half ml fractions. 
Mercaptoethanol Reduaion.--Serum 1 was dialyzed against 0.1, 0.2, and 0.3 ~ 2-mercapto- 
ethanol for 48 hr,  then against 0.01 g  iodoacetamide for 48 hr,  and then against buffered 
saline for 48 hr. P-K studies were compared before and after mercaptoethanol treatment. 
RESULTS 
Throughout the  study,  either  the  whole  serum or  a  fraction obtained by 
one of the fractionation methods was studied for its capacity to give a positive 
P-K  test.  The whole  serum  or  fraction was  also  evaluated for  the  type  of 
immunoglobulin present  by  immuno- and  radioimmunoelectrophoresis, and 
then for antibody content by the ammonium sulfate test or by hemagglutina- 
tion. In whole serum, precipitating ability was measured by gel diffusion and 
the P-80 test. 
Studies of Whole Serum/.--Some  of the reaginic properties of serum 1 are 
presented in Tables I  and II. A  1:32 dilution of serum was capable of passively 
transferring skin reactivity to crystalline BSA and a  1:16 serum dilution trans- 
ferred reactivity to Cynodon daaylon. After heating the serum to 56°C for 4 hr, 
reactivity against both BSA and Cynodon  dactylon  was completely abolished. 
Tests for duration of reactivity at the passively transferred sites showed there 
was no reduction in the strength of reaction for at least i4 days following injec- 
tion of sermn into the test site. As previously reported (39, 40) treatment with 
0.1  •  mercaptoethano]  almost  completely  destroyed  P-K  reactivity to  the 
pollen antigen, but reactivity to BSA was much less affected. After treatment 
with 0.2 and 0.3 ~t mercaptoethanol, however, reaginic activity to both antigens 
was  completely destroyed.  To  verify  that  0.1  ~t  mercaptoethanol had  been ROBERT  T. REID, PERCY  MINDEN,  AND  RICHARD  S. FARR  849 
effective  in  splitting  disulfide  bonds  in  those  immunoglobulins  sensitive  to 
disulfide  splitting  agents,  this  patient's  isoagglutinin  titers  were  compared 
before and after treatment with 0.1 ~  mercaptoethanol. Before treatment, the 
TABLE I 
Prausnitz-Kgstner Titer to BSA and Cynodon  Dactylon  before and after Heating 
to 56°C for 4 Hr, and Treatment  with Mercaptoethanol 
Whole serum  Heated serum  Mercaptoethanol-treated  serum 
Seruul 
dilution 
1:1 
1:2 
1:4 
1:8 
1:16 
1:32 
1:64 
BSA 1 
mg/ml 
di 
4+ 
4+ 
4+ 
3+ 
2+ 
2+ 
C  y~. 
BSA 1  dact. 
mg/ml  1:10 
dilutio 
0  0 
0.1 M  0.2  M 
mg/ml  1:10  mg/ml  1:10 
di~tkn  [__1  dilution 
3-t-]  1+  0  0 
3+  I  4-  0  0 
2+  4-  0  0 
2+  0  0  0 
0.3 M 
Cyn. 
BSA  1  dact. 
mg/ml  l: 10 
dilution 
o--o 
:1: 
0  0 
0  0 
0  0 
0  0 
0  0 
0  0 
TABLE II 
Changes in Antibody Activity before and after Heating to 56°C for 4 hr, or 
Treatmen  with Mercaptoethanol 
ABC-33 at 0.02y-I*BSA 
N/m] 
Hemagglutination titer 
P-80 at 0.027-I* BSA ~/rnl 
Immunodiffusion  band 
PCA (guinea pig) 
Whole 
serum 
7.3 
1:64 
None 
None 
None 
Heated serum  Mercaptoethanol-treated  serum 
5.2 
1:16 
None 
Not done 
Not done 
0.1 M~. 
4.5 
None 
None 
Not done 
Not done 
02 M 
4,8 
None 
None 
Not done 
Not done 
0.3  M 
4.2 
None 
Not done 
Not done 
:~ 0.1 ~ 2-mercaptoethanol in phosphate-buffered  saline pH 7.0. 
anti-A and anti-B titers were 1 : 112 and 1 : 244 respectively, and after treatment, 
both titers fell to zero. 
The  specific antigen-binding  capacity of this  serum  to  BSA was  measured 
by the ammonium sulfate test before and  after heating the serum for 4  hr to 
56°C,  before, and after decomplementing and before and after treatment with 
various  concentrations  of mercaptoethanol  (Table II).  An untreated  control 
sample had an ABC-33 of 7.3 3'. Mter heat treatment, or decomplementation, 850  Rt~AGINIC  ACTIVITY  AND  IoG  IMMUNOGLOBULIN 
the ABC-33 value fell to 5.2 % After mercaptoethanol treatment, it fell to 4.5 % 
This  reduction  in  antibody-binding  capacity  may  simply  he  a  reflection  of 
protein destruction as a result of the physical or chemical treatmenls employed. 
However, a  reduction of specific reaginic antibody cannot be excluded. There 
was complete loss of hemagglutinating capacity after treatment with the various 
dilutions of mercaptoethanol, but after heating, this was only partial. 
P-80  and  microimmunodiffusion studies  with  this  serum revealed that  the 
antil;ody with capacity to kind BSA did not have the capacity to precipitate 
BSA. This is in keeping with previous observations that human sera containing 
FIO.  1.  Immunoelectrophoresis and  radioimmunoelectrophoresis of whole serum utilizing 
I*BSA in the radioimmunoelectrophoresis slides. 
anti-BSA  with  or  without  reagin  activity  tend  to  have  very  low  antigen- 
precipitating efficiencies  (41). 
PCA studies showed no evidence of antibody activity in this serum although 
there was a strongly positive reaction with the control rabbit anti-BSA serum 
that had comparable antigen-binding capacity. 
Radioimmunoelectrophoresis studies  (see Fig.  1)  clearly demonstrated that 
this serum contained IgG as well as IgA with capacity to bind I*BSA. Grossly 
at least, it appeared that the faster migrating IgG globulin bound more I*BSA 
than did the less highly charged IgG globulin, an observation in keeping with 
the Pevikon electrophoretic data. The radioimmnnoelectrophoresis plates before 
and  after treatment with  heat or mercaptoethanol were grossly similar, indi- 
cating that these procedures did not affect the migrational characteristics or the 
I*BSA binding capacities of either IgG or IgA. ROBERT  T.  PCEID)  PERCY MINDEN)  AND  RICHARD  S.  FARR  851 
DEAE Fractionation of Serum /.--(See Fig.  2)  P-K activity against  BSA 
was limited to peaks 1 and 2 which contained only IgG by immuno- and radio- 
immunodectrophoresis arcs whereas peak 3, which was devoid of P-K activity, 
contained the only detectable IgA and minute amounts of IgG. It would appear, 
that the reagin under study was separated from the IgA and separated with 
immunoglobulins of the IgG class. When antigen-binding capacity and hemag- 
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FIG. 2. DEAE fractionafion of reaginic activity. Anion exchange chromatography (DEAE) 
of serum I. P-K activity is limited to peaks I and 2 which contain IgG and are devoid  of IgA. 
No P-K activity was noted in peak 3 which contained the bulk of Igh. The majority d anti- 
body activity by ABC and hemagglutinatlon is in peak 1. 
glutination  tests were performed,  the majority of antibody activity was  in 
peak 1 with lesser  activity in peaks 2 and 3. Peaks 2 and 3 both  bound 0.4 
~'-I*BSA  N/ml  but peak  2 had  2+  reaginic  activity and  peak  3  had none. 
Precipitating activity was not present in any fraction. 
Pevikon Electropk~elic Fradionation of Serum/.--(See Fig. 3) P-K activity 
dosdy followed the distribution of the faster migrating IgG globulin as identi- 
fied  by  immuno-  and  radiolmmunoelectrophoresis.  Fractions  4  through  7 
which contained the bulk of P-K activity did not contain demonstrable IgA as 852  P~AGINIC  ACTIVITY AND IGG IMM'UNOGLOBULIN 
measured by immuno- or radiohnmunoelectrophoresis.  P-K activity was also 
found in fractions 2 and 3 which were on the cathode side of the point of appli- 
cation  (fraction 4).  Fractions  8,  9,  and  10 were not helpful in  determining 
whether P-K reactivity was associated with IgA or IgG because these fractions 
contained both classes of immunoglobulin which bound I*BSA as detected with 
radioimmunoelectrophoresis.  ABC-33  values  closely  correlated  to  the  areas 
where reaginic  activity was isolated although  other methods of fractionation 
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FIG, 3. Pevikon fractionation  of reaginic activity.  Pevikon block fractionation  of whole 
serum  1. P-K activity closely follows the faster  migrating IgG globulin, Fractions  with the 
bulk of P-K activity do not contain IgA by YEP. 
were able to dissociate much, but not all, of the I*BSA-binding capacity from 
P-K activity. 
Sephadex G-200 Fravtionation of Serum/.--(See  Fig.  4)  P-K activity was 
present in fraction pools H, I, and J. Most of the reaginic activity was detected 
in pool J which contained IgG and no IgA as detected by radioimmunoelectro- 
phoresis.  Pool I with less P-K reactivity contained IgG but no detectable IgA. 
Although pool H  did not contain detectable IgG, it did have some P-K reac- 
tivity and some IgA. Pool G was of interest because it contained the bulk of the 
IgA by radioimmunoelectrophoresis yet contained no P-K reactivity. Neither 
P-K nor antibody activity was detected in fraction pools A through D, which 1.0- 
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would  have  contained  any  macroimmunoglobulin  directed  against  BSA. 
Thus,  it  would  appear that  P-K activity was  again more closely associated 
with IgG than with IgA. It was of interest to note that fractionation by gel 
#3 
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1~o. 4. Sephadex G-200 fractionation of reaginic activity. G-200 fractionation of serum 1. 
Most of the P-K activity is in pool J which cont-;ns IgG andno IgA by IEP. No P-K ac- 
tivity was detected in pool G which contains the bulk of IgA. 
TABLE HI 
Highe~l Dilution of DEAE P~ks from Sera 2, 3, 4, and 5 ~ohere P-K Acti~#y 
was 2+ or Higher 
Serum  No... 
Antigen 
DEAE peak 1.. 
DEA~ peak 2 ....... 
DEAE peak 3 
DEAE peak 4... 
Lollum 
~6rmm 
1:20 
0 
1:80 
0 
Ho~e 
dust 
1:40 
0 
1:150 
0 
Ho~e 
dander 
1:80 
1:80 
1:80 
0 
LoUum 
t~'renm 
1:20 
1:40 
1:80 
0 
Lollum  House 
~rsnr~  dust 
1:1  1:40 
1:10  1:40 
1:10  0 
0  0 
filtration  is the method  of choice for separating  the bulk of antigen-binding 
capacity :from the bulk of P-K activity in this particular serum. It is stressed, 
however, that fractions have never been found which contained P-K activity 
in the absence of antigen-binding capacity. 
Density  C-radiant  Fractitmatitm  of Serum  L--The  density  gradient  studies 
revealed that the bulk of this patient's IgA had sedimentation characteristics 854  KEAGINIC  ACTIVITY  AND  IGG  ~OGLOBULIN 
s{m~l~r to the bulk of the IgG and P-K reactivity was associated  with these 
fractions. This method of protein fractionation, therefore,  was not useful in 
distinguishing between reaginic activity associated with IgG or IgA. 
DEAF_, Fraaionation  of Sera 2, 3, 4, and 5.--The P-K activity in fractions 
obtained by DEAE chromatography of the four other sera  are described  in 
Table III. In each instance,  definite P-K activity was noted in fractions from 
peak 1. In serum 5, there was no activity in peak 3 to house dust although there 
was a reaction to Cynodon dactylon demonstrating that heterogeneity of reagin 
molecules must exist in the same individual.  In serum  1 (see Fig.  2), reagin 
activity was confined to peaks 1 and 2. 
DISCUSSION 
The studies described above demonstrate that the majority or all the reagin 
in serum 1 was not an IgA because (a) when whole serum was fractionated by 
anion exchange chromatography, activity was associated  with fractions con- 
raining only IgG and those fractions that contained most of the IgA and only 
trace amounts of IgG were devoid of activity; (b) separation of serum proteins 
by Pevikon block  electrophoresis  revealed  that the largest amount of skin- 
sensitizing  antibody was  in  those fractions with  only IgG.  Some  activity, 
however,  was  demonstrable in fractions containing both IgG and IgA; and 
(c) separation of serum proteins by gel filtration revealed the majority of P-K 
activity was  associated  with IgG. Only one fraction with IgA but with no 
demonstrable IgG, had slight reactivity. 
For the same reasons, the reagin in this serum would appear to be an IgG 
globlllin. However,  the elution properties  from Sephadex G-200 and the speed 
of migration on Pevikon block electrophoresis, suggest that this reagin does not 
belong to the mass of IgG but is associated with a distinct subgroup of the IgG 
globnllns which are either larger, of a different configuration, and/or of slightly 
higher charge than the majority of the IgG globulins. 
Using all techniques,  skin reactivity was not associated  with fractions con- 
taining IgM. Recently, a new class of immunoglobulin has been reported by 
Rowe and Fahey (42) and designated as IgD. The reagin studied in serum 1 does 
not seem to be IgD because it is eluted from the DEAE column before trans- 
ferrin and at a lower molarity than described for IgD. 
It has been well established that the immunoglobulins axe complex proteins 
made up of two kinds of polypeptide chains each under separate genetic control 
and held together by disulfide bonds (43). The light chains, of either the K or L 
types, are present in nearly all known antibodies regardless of the type of heavy 
chain, and heterologous antisera directed against human light chains will react 
with all known classes of human immunoglobulin. The heavy chains differ in 
structure for  each  class  of immunoglobulin  and  these structural differences 
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immunoglobulins.  Further,  antigenic  differences between the various types of 
heavy chain are the basis for the currently used classification  of immunoglobu- 
lins.  The work of Ishizaka  et al.  (18) suggests that  the portion of antibody 
molecule responsible  for reaginic  activity in the IgA system is associated with 
the heavy chain of this  class of antibody. It is now clear,  however, that the 
capacities to fix to skin and elicit a wheal and erythema reaction are qualities 
which occur in immunoglobulins  other than IgA. As demonstrated by this and 
other reports, a positive P-K test crosses the current immunoglobulin classifica- 
tion boundary based on the immunospecificity of the heavy chain and indicates 
that reaginic qualities are not simply a matter of the presence or absence of an 
IgA heavy chain.  Since P-K activity is not limited to IgA heavy chain,  at least 
four additional possibilities become plausible and deserve further consideration: 
(a)  that  each  class  of immunoglobulin  has a  heavy chain  subgroup with  a 
common structttral moiety with capacity to confer reaginic  activity. According 
to this notion, if the skin-fixing moiety of the different immunoglobulins  were 
identical  for  each  immunoglobulin  class,  the skin-fixing  group  is  either  not 
antigenic or it is not detected by the typing antisera currently available; (b) that 
each  class  of immunoglobulin has a  heavy chain subgroup with a  structural 
moiety with capacity to confer reaginic activity but that this moiety is distinct 
and  unique for each major  class  of immunoglobulin.  This  skin-fixing  group 
could be confined to the Fd or the Fc portion, or may be a property of the intact 
heavy chain;  (c) since reaginic  activity can no longer  be considered  a unique 
property of IgA, the skin-fixing characteristic of reagin may be determined by 
the light chain, regardless  of its associated heavy chain; and (d) the skin-fixing 
properties are the result of the steric configuration  resulting from coupling  of 
light to heavy chains without regard to the class of light or heavy chains in- 
volved. 
The relative frequency of reaginic  activity in the lgG fraction, as compared 
to the frequency of such activity in the IgA fractions is currently not known. 
The finding of reaginic  activity in the IgG fractions of sera from the four other 
patients tested (Table III) indicates that the presence of reagin in IgG is not an 
infrequent phenomenon. The clinical significance and relative importance of the 
presence of IgG type of reagin must await further study. 
s~Y 
Five human sera with reaginic  activity to a number of allergens  were frac- 
tionated using anion exchange chromatography. In each serum, fractions which 
contained detectable IgG and no detectable IgA had capacity to fix to skin and 
subsequently elicit a P-K reaction. Four of these sera had reaginic activity about 
equally distributed between fractions containing  only IgG and fractions con- 
taining mixtures of IgG and IgA. A fifth serum contained reaginic  activity to 
crystalline bovine serum albumin  (BSA)  and most of the activity was asso- 856  REAGINIC  ACTIVITY  AND  IGG  IMMUNOGLOBULIN 
ciated with the fraction which contained only IgG. This serum was extensively 
studied using a  variety of techniques and it was confirmed that most of the 
reagin to BSA in this serum was in those fractions containing only IgG. Since 
reaginic activity can no longer be considered a  unique property of IgA  the 
implications  of finding  antibod)  with  reaginic  qualities  in  immunoglobnlins 
other than IgA are discussed. 
The authors are grateful for the technical assistance of Miss Donna Mason, Mr. Richard 
Mays, and Mrs. Dru Richardson in performance  of much of the work in this paper. 
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